reviewJournal of Peptide ScienceJan 1, 2016HYBRID OA

Advances in Fmoc solid‐phase peptide synthesis

MSD (Switzerland) · Merck Serono S.A. (Switzerland) · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Today, Fmoc SPPS is the method of choice for peptide synthesis. Very-high-quality Fmoc building blocks are available at low cost because of the economies of scale arising from current multiton production of therapeutic peptides by Fmoc SPPS. Many modified derivatives are commercially available as Fmoc building blocks, making synthetic access to a broad range of peptide derivatives straightforward. The number of synthetic peptides entering clinical trials has grown continuously over the last decade, and recent advances in the Fmoc SPPS technology are a response to the growing demand from medicinal chemistry and pharmacology. Improvements are being continually reported for peptide quality, synthesis time and…

Citation impact

737
total citations
FWCI
29.59
Percentile
100%
References
291
Citations per year

Authors

3

Topics & keywords

Keywords
  • Peptide synthesis
  • Peptide
  • Combinatorial chemistry
  • Solid-phase synthesis
  • Chemistry
  • Nanotechnology
  • Materials science
  • Biochemistry
No related works found for this paper.